Page last updated: 2024-08-21

evans blue and glyceraldehyde 3-phosphate

evans blue has been researched along with glyceraldehyde 3-phosphate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Date, I; Liu, K; Maruo, T; Mori, S; Nishibori, M; Ohtsuka, A; Okuma, Y; Otani, N; Shima, K; Takahashi, HK; Tomura, S; Wake, H; Yamamoto, H; Yamamoto, Y; Yoshino, T; Zhang, J1

Other Studies

1 other study(ies) available for evans blue and glyceraldehyde 3-phosphate

ArticleYear
Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
    Annals of neurology, 2012, Volume: 72, Issue:3

    Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Evans Blue; Functional Laterality; Gene Expression Regulation; Glycation End Products, Advanced; Glyceraldehyde 3-Phosphate; HMGB1 Protein; Hypoxia-Inducible Factor 1; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Motor Activity; Neurons; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Rotarod Performance Test; Toll-Like Receptor 2; Toll-Like Receptor 4

2012